ANEB
ANEB
NASDAQ · Pharmaceuticals

Anebulo Pharmaceuticals Inc

$0.33
+0.01 (+3.13%)
As of Aug 8, 2:27 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +15,048.5% upside
Low Target $34.23
Average Target $49.99
High Target $60.95
Current Price $0.33
Current
$0.33
Target
$49.99
$34.23 $49.99 avg $60.95
Scenario Analysis
Bear Case
$34.23
10,272.7%
Low target
Base Case
$49.99
+15,048.5%
Avg target
Bull Case
$60.95
+18,369.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$49.99
+1,623.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%